{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:52:10Z","timestamp":1789051930249,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.medcli.2024.12.005","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T23:27:14Z","timestamp":1738106834000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["C\u00e1ncer de tiroides"],"prefix":"10.1016","volume":"164","author":[{"given":"Jordi L.","family":"Reverter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.12.005_bib0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.medcli.2024.12.005_bib0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO Classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/thy.2010.0021","article-title":"Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006","volume":"21","author":"Aschebrook-Kilfoy","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0320","unstructured":"Surveillance Research Program. SEER incidence data, November 2022 Submission (1975-2020), SEER 22 registries (excluding Illinois and Massachusetts). National Cancer Institute. Updated June 8, 2023 [consultado 2 Sep 2024]. Disponible en: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/"},{"key":"10.1016\/j.medcli.2024.12.005_bib0325","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1097\/JS9.0000000000001767","article-title":"Thyroid cancer-specific mortality during 2005-2018 in Korea, aftermath of the overdiagnosis issue: A nationwide population-based cohort study","volume":"110","author":"Kim","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.medcli.2024.12.005_bib0330","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.12.005_bib0335","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: A review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2024.12.005_bib0340","doi-asserted-by":"crossref","first-page":"116789","DOI":"10.1016\/j.ecoenv.2024.116789","article-title":"Recent insights into trends of thyroid cancer incidence in Lithuanian population exposed to Chernobyl fallout early in life","volume":"283","author":"Steponaviciene","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.medcli.2024.12.005_bib0345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2024.12.005_bib0350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-29998-3_3","article-title":"Diagnosis and Management of Hereditary Thyroid Cancer","volume":"205","author":"Bano","year":"2016","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.medcli.2024.12.005_bib0355","first-page":"676","article-title":"Cancer Genome Atlas Research Network","volume":"159","year":"2014","journal-title":"Integrated genomic characterization of papillary thyroid carcinoma. Cell."},{"key":"10.1016\/j.medcli.2024.12.005_bib0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12022-024-09812-5","article-title":"RAS-mutant follicular thyroid tumors: A continuous challenge for pathologists","volume":"35","author":"Hernandez-Prera","year":"2024","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0365","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1530\/EC-20-0374","article-title":"Current status of the prognostic molecular markers in medullary thyroid carcinoma","volume":"9","author":"Oczko-Wojciechowska","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.medcli.2024.12.005_bib0370","doi-asserted-by":"crossref","first-page":"242.e5","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medcli.2024.12.005_bib0375","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/ijem.IJEM_321_19","article-title":"Genetic alterations in anaplastic thyroid carcinoma","volume":"23","author":"Rashid","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.medcli.2024.12.005_bib0380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ph16040559","article-title":"Epigenetic targets and their inhibitors in thyroid cancer treatment","volume":"16","author":"Zhang","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0385","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamaoto.2022.1743","article-title":"Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes: A multinational, multi-institutional analysis","volume":"148","author":"Sajisevi","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.medcli.2024.12.005_bib0390","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/thy.2024.0313","article-title":"Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy","volume":"34","author":"Song","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0395","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/cen.14905","article-title":"Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers","volume":"101","author":"Wadsley","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.medcli.2024.12.005_bib0405","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2008.0210","article-title":"Time trends for thyroid cancer in northwestern Spain: True rise in the incidence of micro and larger forms of papillary thyroid carcinoma","volume":"19","author":"Rego-Iraeta","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0410","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/etm.2021.10039","article-title":"Incidence of thyroid carcinomas in an extended retrospective study of 526 autopsies","volume":"21","author":"Mohorea","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.medcli.2024.12.005_bib0415","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/cancers13092253","article-title":"Differentiated thyroid cancer: A health economic review","volume":"13","author":"Van Den Heede","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0425","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1148\/radiol.2473070944","article-title":"Benign and malignant thyroid nodules: US differentiation-multicenter retrospective study","volume":"247","author":"Moon","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.medcli.2024.12.005_bib0430","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000478927","article-title":"European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS","volume":"6","author":"Russ","year":"2017","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.medcli.2024.12.005_bib0435","first-page":"13","article-title":"Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: Systematic review and meta-analysis","author":"Piticchio","year":"2024","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.medcli.2024.12.005_bib0440","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0023","article-title":"Reliability of a computer-aided system in the evaluation of indeterminate ultrasound images of thyroid nodules","volume":"11","author":"Reverter","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.medcli.2024.12.005_bib0445","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0450","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy rate in thyroid nodules classified as Bethesda category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0455","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/jcm13061759","article-title":"Current state of molecular cytology in thyroid nodules: Platforms and their diagnostic and theranostic utility","volume":"13","author":"Hannoush","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.medcli.2024.12.005_bib0460","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0170","article-title":"Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules: A meta-analysis","volume":"13","author":"Vardarli","year":"2024","journal-title":"Endocr Connect"},{"key":"10.1016\/j.medcli.2024.12.005_bib0465","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/thy.2014.0502","article-title":"American Thyroid Association Surgical Affairs Committee. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making","volume":"25","author":"Ferris","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0470","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/thy.2023.0076","article-title":"Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience","volume":"33","author":"Miyauchi","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0475","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1089\/thy.2019.0159","article-title":"Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis","volume":"29","author":"Cho","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0480","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/thy.2019.0707","article-title":"Efficacy and Safety of Thermal Ablation Techniques for the Treatment of Primary Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis","volume":"30","author":"Choi","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0485","doi-asserted-by":"crossref","first-page":"103204","DOI":"10.1016\/j.amjoto.2021.103204","article-title":"Radiofrequency ablation and thyroid cancer: Review of the current literature","volume":"43","author":"Muhammad","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0490","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","article-title":"Extent of surgery for papillary thyroid cancer is not associated with survival: An analysis of 61,775 patients","volume":"260","author":"Adam","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.medcli.2024.12.005_bib0495","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.surg.2023.05.033","article-title":"Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy","volume":"174","author":"Stevens","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.medcli.2024.12.005_bib0500","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/bjs.8985","article-title":"Prophylactic central neck dissection for papillary thyroid cancer","volume":"100","author":"Barczy\u0144ski","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.medcli.2024.12.005_bib0505","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid."},{"key":"10.1016\/j.medcli.2024.12.005_bib0510","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0084","article-title":"Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: Does it improve postoperative outcome?","volume":"11","author":"Hay","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.medcli.2024.12.005_bib0515","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.12.005_bib0520","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.12.005_bib0525","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.endonu.2010.09.007","article-title":"Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma [Article in Spanish]","volume":"58","author":"Reverter","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.medcli.2024.12.005_bib0530","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.3390\/jcm13133963","article-title":"Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers","volume":"13","author":"Diwanji","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2024.12.005_bib0535","doi-asserted-by":"crossref","first-page":"1405705","DOI":"10.3389\/fendo.2024.1405705","article-title":"Current role of interventional radiology in thyroid nodules","volume":"15","author":"Taydas","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0540","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.2008.0392","article-title":"Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: A systematic review and meta-analysis","volume":"19","author":"Sawka","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.medcli.2024.12.005_bib0545","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers13071625","article-title":"Site-specific metastasis and survival in papillary thyroid cancer: The importance of brain and multi-organ disease","volume":"13","author":"Toraih","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0550","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.endonu.2015.08.007","article-title":"Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer","volume":"63","author":"Riesco-Eizaguirre","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.medcli.2024.12.005_bib0555","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.12.005_bib0560","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2022.04.009","article-title":"ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer","volume":"33","author":"Filetti","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0565","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/cancers11091388","article-title":"BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives","volume":"11","author":"Crispo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2024.12.005_bib0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12672-024-00904-6","article-title":"Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials","volume":"15","author":"Wang","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0575","first-page":"1","article-title":"Multimodal prehabilitation in radioactive iodine-refractory differentiated thyroid cancer treated with lenvatinib","volume":"5","author":"P\u00e9rez-Montes de Oca","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.medcli.2024.12.005_bib0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30723","article-title":"Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paper","volume":"10","author":"Jack","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.medcli.2024.12.005_bib0585","first-page":"27","article-title":"Redifferentiation of radioiodine-refractory thyroid cancers","author":"Buffet","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.medcli.2024.12.005_bib0590","first-page":"16","article-title":"Biology and treatment of medullary thyroid cancer","volume":"101","author":"Fagin","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2024.12.005_bib0595","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000509457","article-title":"Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis","volume":"10","author":"Efstathiadou","year":"2021","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.medcli.2024.12.005_bib0600","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:01:12Z","timestamp":1744430472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0025775325000107"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.12.005","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u00e1ncer de tiroides","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}